Table 1 Cost-effectiveness results from age and risk stratification analyses
Strategy | Mean lifetime cost per patient1 | Mean lifetime QALYs per patient1 | NMB2 at £20,000 per QALY (95% CI) |
|---|---|---|---|
Age group < 65 years | |||
Active monitoring (AM)3 | £15,359 | 15.36 | £290,279 (£281,895 to £295,127) |
Radical prostatectomy (RP) | £12,939 | 15.25 | £290,487 (£280,781 to £296,281)* |
Radiotherapy (RT) | £14,746 | 15.32 | £289,754 (£278,620 to £296,202) |
Age group ≥ 65 years | |||
Active monitoring (AM) | £9444 | 10.23 | £194,153 (£186,516 to £199,781) |
Radical prostatectomy (RP)4 | £10,283 | 10.61 | £201,052 (£195,294 to £204,579) |
Radiotherapy (RT) | £9174 | 10.57 | £201,311 (£195,161 to £205,049)* |
D’Amico low risk group | |||
Active monitoring (AM) | £14,027 | 15.29 | £289,965 (£279,855 to £296,013) |
Radical prostatectomy (RP) | £12,072 | 15.25 | £290,967 (£279,084 to £297,907) |
Radiotherapy (RT) | £11,572 | 15.34 | £293,446 (£282,811 to £299,451)* |
D’Amico intermediate/high risk group | |||
Active monitoring (AM) | £18,297 | 14.30 | £265,526 (£247,010 to £278,307) |
Radical prostatectomy (RP) | £15,323 | 14.70 | £275,977 (£258,630 to £285,474)* |
Radiotherapy (RT) | £15,060 | 14.35 | £268,669 (£246,778 to £282,238) |
Grade group - low risk | |||
Active monitoring (AM) | £14,144 | 15.15 | £287,565 (£278,750 to £293,382) |
Radical prostatectomy (RP) | £12,055 | 15.28 | £292,198 (£283,797 to £297,258) |
Radiotherapy (RT) | £12,041 | 15.31 | £292,736 (£284,074 to £297,719)* |
Grade group - intermediate/high risk | |||
Active monitoring (AM) | £17,838 | 13.90 | £256,111 (£226,180 to £276,399) |
Radical prostatectomy (RP) | £17,645 | 14.78 | £271,933 (£237,864 to £287,784)* |
Radiotherapy (RT) | £16,317 | 13.54 | £248,558 (£207,893 to £274,911) |